- ALBO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Albireo Pharma (ALBO) CORRESPCorrespondence with SEC
Filed: 15 Sep 16, 12:00am
Via Edgar
September 15, 2016
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Suzanne Hayes
Re: | Biodel Inc. |
Amendment No. 2 to Preliminary Proxy Statement on Schedule 14A |
Filed on September 12, 2016 |
File No. 001-33451 |
Dear Ms. Hayes:
Biodel Inc. (the “Company”) is submitting this letter in response to a verbal comment by the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”) received by our outside counsel, Cooley LLP, during a telephone conversation on September 15, 2016 relating to the Company’s Amendment No. 2 to Preliminary Proxy Statement on Schedule 14A filed on September 12, 2016.
In response to the request of the Staff, the Company hereby acknowledges that:
• | The Company is responsible for the adequacy and accuracy of the disclosure in the filing; |
• | Staff comments or changes to disclosure in response to Staff comments do not foreclose the Commission from taking any action with respect to the filing; and |
• | The Company may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. |
We appreciate the Staff’s comment and request that the Staff contact the undersigned at (203) 796-5000, or Miguel J. Vega, outside counsel to the Company at (617) 937-2319, with any questions or comments regarding this letter. Thank you for your assistance.
Sincerely,
BIODEL INC.
/s/ Paul S. Bavier
Paul S. Bavier
Interim President and General Counsel
cc: | Gary G. Gemignani,Biodel Inc. |
Miguel J. Vega,Cooley LLP
Marc Recht,Cooley LLP
Michael Grundei,Wiggin and Dana LLP
Pete Zorn,Albireo Limited
Megan Gates,Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
John Condon,Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.